针对重症监护定制的计算机化决策支持警报对高风险药物组合给药及其监测的影响:一项整群随机阶梯楔形试验
这项在荷兰9个ICU开展的整群随机阶梯楔形试验,纳入9887例成人ICU患者(至少使用两种药物),干预为仅对被认为高风险的潜在药物相互作用提供警报的改良临床决策支持系统(CDSS),并以ICU为单位随机实施顺序。干预组每1000次给药中高风险药物组合给药数为26.2(SD 53.4),对照组为35.6(SD 65.0);调整聚类和预后因素后,干预使该指标降低12%(95%CI 5-18%,p=0.0008)。作者认为,定制警报清单可用于其他ICU,基于临床相关性的警报定制策略可推广至其他临床场景。
要点
- 在9个荷兰ICU的9887例成人患者中,仅提示高风险的定制DDI警报使每1000次给药中高风险药物组合给药数从35.6降至26.2。
- 调整聚类和预后因素后,定制DDI警报使高风险药物组合给药数降低12%(95%CI 5-18%,p=0.0008)。
- 干预为ICU层面、针对医师的改良CDSS,仅对被认为高风险的潜在药物相互作用提供警报。
- 作者认为其高风险药物组合清单可用于其他ICU,基于临床相关性的警报定制策略可推广至其他临床场景。
适用人群与场景
- 荷兰9个ICU中年龄≥18岁、入住ICU且至少使用两种药物的患者。
处置流程与药物剂量
- 干预为改良的临床决策支持系统(CDSS),仅对被认为高风险的潜在药物相互作用提供警报,干预在ICU层面实施并针对医师。
研究设计与关键结果
- 研究类型:在荷兰9个ICU开展的整群随机阶梯楔形试验;2018年9月1日至2019年9月1日评估10423例ICU患者,纳入9887例。
- 干预组(n=5534)每1000次给药中高风险药物组合给药数为26.2(SD 53.4),对照组(n=4353)为35.6(SD 65.0)。
- 调整聚类和预后因素后,定制DDI警报使每1000次给药中高风险药物组合给药数降低12%(95%CI 5-18%,p=0.0008)。
- 试验于2018年11月26日在荷兰试验注册中心注册(标识NL6762),现已关闭。
证据类型、等级与局限
- 证据类型:整群随机阶梯楔形试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,其高风险药物组合清单可用于其他ICU,基于临床相关性的警报定制策略可应用于其他临床场景。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Drug-drug interactions (DDIs) can harm patients admitted to the intensive care unit (ICU). Yet, clinical decision support systems (CDSSs) aimed at helping physicians prevent DDIs are plagued by low-yield alerts, causing alert fatigue and compromising patient safety. The aim of this multicentre study was to evaluate the effect of tailoring potential DDI alerts to the ICU setting on the frequency of administered high-risk drug combinations.
METHODS: We implemented a cluster randomised stepped-wedge trial in nine ICUs in the Netherlands. Five ICUs already used potential DDI alerts. Patients aged 18 years or older admitted to the ICU with at least two drugs administered were included. Our intervention was an adapted CDSS, only providing alerts for potential DDIs considered as high risk. The intervention was delivered at the ICU level and targeted physicians. We hypothesised that showing only relevant alerts would improve CDSS effectiveness and lead to a decreased number of administered high-risk drug combinations. The order in which the intervention was implemented in the ICUs was randomised by an independent researcher. The primary outcome was the number of administered high-risk drug combinations per 1000 drug administrations per patient and was assessed in all included patients. This trial was registered in the Netherlands Trial Register (identifier NL6762) on Nov 26, 2018, and is now closed.
FINDINGS: In total, 10 423 patients admitted to the ICU between Sept 1, 2018, and Sept 1, 2019, were assessed and 9887 patients were included. The mean number of administered high-risk drug combinations per 1000 drug administrations per patient was 26·2 (SD 53·4) in the intervention group (n=5534), compared with 35·6 (65·0) in the control group (n=4353). Tailoring potential DDI alerts to the ICU led to a 12% decrease (95% CI 5-18%; p=0·0008) in the number of administered high-risk drug combinations per 1000 drug administrations per patient, after adjusting for clustering and prognostic factors.
INTERPRETATION: This cluster randomised stepped-wedge trial showed that tailoring potential DDI alerts to the ICU setting significantly reduced the number of administered high-risk drug combinations. Our list of high-risk drug combinations can be used in other ICUs, and our strategy of tailoring alerts based on clinical relevance could be applied to other clinical settings.
参考来源
- Bakker T, Klopotowska JE, Dongelmans DA, et al. The effect of computerised decision support alerts tailored to intensive care on the administration of high-risk drug combinations, and their monitoring: a cluster randomised stepped-wedge trial. Lancet. 2024. PMID: 38262430. doi:10.1016/S0140-6736(23)02465-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。